IBDEI09R ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4143,1,3,0)
 ;;=3^SCREEN-YAWS
 ;;^UTILITY(U,$J,358.3,4143,1,4,0)
 ;;=4^V74.6
 ;;^UTILITY(U,$J,358.3,4143,2)
 ;;=^295638
 ;;^UTILITY(U,$J,358.3,4144,0)
 ;;=V74.8^^17^196^7
 ;;^UTILITY(U,$J,358.3,4144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4144,1,3,0)
 ;;=3^SCREEN-BACTERIAL DIS NEC
 ;;^UTILITY(U,$J,358.3,4144,1,4,0)
 ;;=4^V74.8
 ;;^UTILITY(U,$J,358.3,4144,2)
 ;;=^295639
 ;;^UTILITY(U,$J,358.3,4145,0)
 ;;=V75.0^^17^196^55
 ;;^UTILITY(U,$J,358.3,4145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4145,1,3,0)
 ;;=3^SCREEN-RICKETTSIAL DIS
 ;;^UTILITY(U,$J,358.3,4145,1,4,0)
 ;;=4^V75.0
 ;;^UTILITY(U,$J,358.3,4145,2)
 ;;=^295641
 ;;^UTILITY(U,$J,358.3,4146,0)
 ;;=V75.1^^17^196^39
 ;;^UTILITY(U,$J,358.3,4146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4146,1,3,0)
 ;;=3^SCREEN-MALARIA
 ;;^UTILITY(U,$J,358.3,4146,1,4,0)
 ;;=4^V75.1
 ;;^UTILITY(U,$J,358.3,4146,2)
 ;;=^295642
 ;;^UTILITY(U,$J,358.3,4147,0)
 ;;=V75.2^^17^196^36
 ;;^UTILITY(U,$J,358.3,4147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4147,1,3,0)
 ;;=3^SCREEN-LEISHMANIASIS
 ;;^UTILITY(U,$J,358.3,4147,1,4,0)
 ;;=4^V75.2
 ;;^UTILITY(U,$J,358.3,4147,2)
 ;;=^295643
 ;;^UTILITY(U,$J,358.3,4148,0)
 ;;=V75.3^^17^196^61
 ;;^UTILITY(U,$J,358.3,4148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4148,1,3,0)
 ;;=3^SCREEN-TRYPANOSOMIASIS
 ;;^UTILITY(U,$J,358.3,4148,1,4,0)
 ;;=4^V75.3
 ;;^UTILITY(U,$J,358.3,4148,2)
 ;;=^295644
 ;;^UTILITY(U,$J,358.3,4149,0)
 ;;=V75.4^^17^196^43
 ;;^UTILITY(U,$J,358.3,4149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4149,1,3,0)
 ;;=3^SCREEN-MYCOTIC INFECT
 ;;^UTILITY(U,$J,358.3,4149,1,4,0)
 ;;=4^V75.4
 ;;^UTILITY(U,$J,358.3,4149,2)
 ;;=^295645
 ;;^UTILITY(U,$J,358.3,4150,0)
 ;;=V75.5^^17^196^56
 ;;^UTILITY(U,$J,358.3,4150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4150,1,3,0)
 ;;=3^SCREEN-SCHISTOSOMIASIS
 ;;^UTILITY(U,$J,358.3,4150,1,4,0)
 ;;=4^V75.5
 ;;^UTILITY(U,$J,358.3,4150,2)
 ;;=^295646
 ;;^UTILITY(U,$J,358.3,4151,0)
 ;;=V75.6^^17^196^22
 ;;^UTILITY(U,$J,358.3,4151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4151,1,3,0)
 ;;=3^SCREEN-FILARIASIS
 ;;^UTILITY(U,$J,358.3,4151,1,4,0)
 ;;=4^V75.6
 ;;^UTILITY(U,$J,358.3,4151,2)
 ;;=^295647
 ;;^UTILITY(U,$J,358.3,4152,0)
 ;;=V75.7^^17^196^29
 ;;^UTILITY(U,$J,358.3,4152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4152,1,3,0)
 ;;=3^SCREEN-HELMINTHIASIS
 ;;^UTILITY(U,$J,358.3,4152,1,4,0)
 ;;=4^V75.7
 ;;^UTILITY(U,$J,358.3,4152,2)
 ;;=^295648
 ;;^UTILITY(U,$J,358.3,4153,0)
 ;;=V75.8^^17^196^48
 ;;^UTILITY(U,$J,358.3,4153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4153,1,3,0)
 ;;=3^SCREEN-PARASITIC DIS NEC
 ;;^UTILITY(U,$J,358.3,4153,1,4,0)
 ;;=4^V75.8
 ;;^UTILITY(U,$J,358.3,4153,2)
 ;;=^295649
 ;;^UTILITY(U,$J,358.3,4154,0)
 ;;=V76.0^^17^196^77
 ;;^UTILITY(U,$J,358.3,4154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4154,1,3,0)
 ;;=3^SCRN MAL NEOP RESP ORG
 ;;^UTILITY(U,$J,358.3,4154,1,4,0)
 ;;=4^V76.0
 ;;^UTILITY(U,$J,358.3,4154,2)
 ;;=^295651
 ;;^UTILITY(U,$J,358.3,4155,0)
 ;;=V76.10^^17^196^66
 ;;^UTILITY(U,$J,358.3,4155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4155,1,3,0)
 ;;=3^SCRN MAL NEOP BREAST
 ;;^UTILITY(U,$J,358.3,4155,1,4,0)
 ;;=4^V76.10
 ;;^UTILITY(U,$J,358.3,4155,2)
 ;;=^317968
 ;;^UTILITY(U,$J,358.3,4156,0)
 ;;=V76.11^^17^196^71
 ;;^UTILITY(U,$J,358.3,4156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4156,1,3,0)
 ;;=3^SCRN MAL NEOP MAMMO HIGH RISK PT
 ;;^UTILITY(U,$J,358.3,4156,1,4,0)
 ;;=4^V76.11
 ;;^UTILITY(U,$J,358.3,4156,2)
 ;;=^317969
 ;;^UTILITY(U,$J,358.3,4157,0)
 ;;=V76.12^^17^196^70
 ;;^UTILITY(U,$J,358.3,4157,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI09R
